Published in Drugs on January 01, 1989
Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol (2011) 1.69
Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected role. Agents Actions (1993) 0.85
Clinical relevance of intracellular and extracellular concentrations of macrolides. Infection (1995) 0.83
Inhibition of sulfur mustard-induced cytotoxicity and inflammation by the macrolide antibiotic roxithromycin in human respiratory epithelial cells. BMC Cell Biol (2007) 0.81
Pharmacoeconomic evaluation of roxithromycin versus amoxycillin/clavulanic acid in a community-acquired lower respiratory tract infection study. Infection (1995) 0.79
Tacrolimus (FK506) suppresses TREM-1 expression at an early but not at a late stage in a murine model of fungal keratitis. PLoS One (2014) 0.78
Advances in the Prevention of Infection-Related Preterm Birth. Front Immunol (2015) 0.76
Roxithromycin 150 mg b.i.d. versus amoxycillin 500 mg/clavulanic acid 125 mg t.i.d. for the treatment of lower respiratory tract infections in general practice. Infection (1995) 0.75
Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med (1995) 2.27
Tiaprofenic acid. A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases and pain states. Drugs (1985) 2.26
A real-time RT-PCR method for the universal detection and identification of flaviviruses. Vector Borne Zoonotic Dis (2007) 2.05
Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs (1988) 1.82
Identification of Rickettsia spp. and Bartonella spp. in ffrom the Thai-Myanmar border. Ann N Y Acad Sci (2003) 1.76
Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs (1993) 1.71
Subgroups, serotypes, and electrophoretypes of rotavirus isolated from children in Bangui, Central African Republic. J Clin Microbiol (1988) 1.54
Distribution of Crimean-Congo hemorrhagic fever viral antibody in Senegal: environmental and vectorial correlates. Am J Trop Med Hyg (1990) 1.40
HFRS after a wild rodent bite in the Haute-Savoie--and risk of exposure to Hantaan-like virus in a Paris laboratory. Lancet (1984) 1.38
Type 1 wild poliovirus and putative enterovirus 109 in an outbreak of acute flaccid paralysis in Congo, October-November 2010. Euro Surveill (2010) 1.38
[Serological survey for the prevalence of certain arboviruses in the human population of the south-east area of Central African Republic (author's transl)]. Bull Soc Pathol Exot Filiales (1982) 1.38
Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. Drugs (1987) 1.33
Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1985) 1.29
Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs (1989) 1.25
Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs (1993) 1.25
Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs (1990) 1.22
[Sylvatic yellow fever in Africa recent advances and present approach (author's transl)]. Med Trop (Mars) (1981) 1.16
First human case of haemorrhagic fever with renal syndrome in the Central African Republic. Trans R Soc Trop Med Hyg (1987) 1.13
Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué. Trans R Soc Trop Med Hyg (1982) 1.10
Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris. Drugs (1988) 1.07
Arbovirus infections and viral haemorrhagic fevers in Uganda: a serological survey in Karamoja district, 1984. Trans R Soc Trop Med Hyg (1990) 1.06
[Dengue in Burkina Faso (ex-Upper Volta): seasonal epidemics in the urban area of Ouagadougou]. Bull Soc Pathol Exot Filiales (1985) 1.06
Changes in Rift Valley fever neutralizing antibody prevalence among small domestic ruminants following the 1987 outbreak in the Senegal River basin. Res Virol (1991) 1.06
An arenavirus isolated from wild-caught rodents (Pramys species) in the Central African Republic. Intervirology (1983) 1.05
[Crimean-Congo hemorrhagic fever in Senegal. Latest data on the ecology of the CCHF virus]. Bull Soc Pathol Exot (1994) 1.05
Filovirus activity among selected ethnic groups inhabiting the tropical forest of equatorial Africa. Trans R Soc Trop Med Hyg (1994) 1.05
Pravastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. Drugs (1991) 1.04
Mesalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease. Drugs (1989) 1.03
Evolution of the Old World Arenaviridae and their rodent hosts: generalized host-transfer or association by descent? Infect Genet Evol (2001) 1.02
Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs (1987) 1.02
Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs (1995) 1.02
Dothiepin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs (1989) 1.02
Insect densoviruses may be widespread in mosquito cell lines. J Gen Virol (1995) 1.01
Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease. Drugs (1989) 1.01
Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension. Drugs (1989) 1.00
Diltiazem. A reappraisal of its pharmacological properties and therapeutic use. Drugs (1990) 0.99
Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma. Drugs (1994) 0.99
Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia. Drugs (1993) 0.98
Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs (1986) 0.97
[Antibodies against the Marburg virus among human populations in the southeastern Central African Republic]. C R Seances Acad Sci III (1981) 0.96
Clinical aspects and usefulness of indirect absorbed immunofluorescence for diagnosis of yaws in Central Africa. J Clin Microbiol (1988) 0.96
Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia. Drugs (1995) 0.95
[Parasites of fresh water turtles in Tunisia]. Arch Inst Pasteur Tunis (1978) 0.93
Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis. Drugs (1994) 0.93
Loratadine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1989) 0.92
Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs (1988) 0.91
Selegiline. A review of its pharmacology, symptomatic benefits and protective potential in Parkinson's disease. Drugs Aging (1991) 0.90
Ocular metipranolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in glaucoma and ocular hypertension. Drugs (1988) 0.90
Review of cimetidine drug interactions. Drug Intell Clin Pharm (1983) 0.90
Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs (1989) 0.90
Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs (1986) 0.89
Evolutionary biology of a Lassa virus complex. Med Microbiol Immunol (1986) 0.89
Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders. Drugs (1996) 0.89
[Current serologic data on viral hemorrhagic fevers in the Central African Republic]. Bull Soc Pathol Exot Filiales (1987) 0.89
The potential role of rodents in the enzootic cycle of Rift Valley fever virus in Senegal. Microbes Infect (2000) 0.89
True HIV-1 infection in a pygmy. Lancet (1987) 0.88
[Descriptive epidemiology of Rift Valley fever in small ruminants in Southern Mauritania after the 1988 rainy season]. Rev Elev Med Vet Pays Trop (1990) 0.88
Effects of elevated calcium and calcium antagonists on 6,7-benzomorphan-induced analgesia. Eur J Pharmacol (1983) 0.88
[Serological approach to the occurrence of rickettsioses in the Central African Republic]. Bull Soc Pathol Exot Filiales (1985) 0.88
Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy. Drugs (1993) 0.88
Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma. Drugs (1993) 0.87
Sizing up human health through remote sensing: uses and misuses. Parassitologia (2005) 0.87
Haemorrhagic fever virus activity in equatorial Africa: distribution and prevalence of filovirus reactive antibody in the Central African Republic. Trans R Soc Trop Med Hyg (1994) 0.85
Antibodies to Lassa and Lassa-like viruses in man and mammals in the Central African Republic. Trans R Soc Trop Med Hyg (1985) 0.85
Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease. Drugs (1990) 0.85
Serological study of hantavirus in the rodent population of Nakhon Pathom and Nakhon Ratchasima Provinces Thailand. Southeast Asian J Trop Med Public Health (2000) 0.85
Milrinone. A preliminary review of its pharmacological properties and therapeutic use. Drugs (1988) 0.85
Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs Aging (1994) 0.84
Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension. Drugs (1988) 0.84
Esmolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs (1987) 0.84
Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension. Drugs (1989) 0.84
Further case of haemorrhagic fever with renal syndrome in France. Lancet (1983) 0.83
[Arbovirosis from Central African Republic: incidence, diagnosis in human pathology (author's transl)]. Med Trop (Mars) (1981) 0.83
Comparison of Lassa, Mobala, and Ippy virus reactions by immunofluorescence test. Lancet (1985) 0.83
Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases. Drugs (1987) 0.83
Leuprorelin. A review of its pharmacology and therapeutic use in prostatic disorders. Drugs Aging (1992) 0.82
Transmission of Crimean-Congo haemorrhagic fever virus from experimentally infected sheep to Hyalomma truncatum ticks. Res Virol (1992) 0.82
Serological evidence of endemic Zinga virus and Rift Valley Fever virus in Central African Republic. Lancet (1983) 0.82
Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension. Drugs Aging (1992) 0.82
Abciximab (c7E3 Fab). A review of its pharmacology and therapeutic potential in ischaemic heart disease. Drugs (1994) 0.82
Serological and biological evidence that Lassa-complex arenaviruses are widely distributed in Africa. Med Microbiol Immunol (1986) 0.82
Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders. Drugs (1993) 0.81
Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia. Drugs Aging (1993) 0.81
Thermostability and efficacy in the field of a new, stabilized yellow fever virus vaccine. Vaccine (1985) 0.81
[Preliminary note on the presence of antibodies to Ebola virus in the human population in the eastern part of the Central African Republic]. Bull Soc Pathol Exot Filiales (1981) 0.81
Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders. Drugs (1994) 0.81
[Epidemiological study of arboviruses in the Central African Republic: demonstration of Chikungunya virus during 1978 and 1979]. Bull Soc Pathol Exot Filiales (1981) 0.81
Serological evidence for Hantaan-related virus in Africa. Lancet (1984) 0.81
[Ebola and Marburg hemorrhagic fever viruses: update on filoviruses]. Med Trop (Mars) (2011) 0.80
Ocular sodium cromoglycate. An overview of its therapeutic efficacy in allergic eye disease. Drugs (1986) 0.80
[Current problems of arboviruses in central Africa]. Bull Soc Pathol Exot Filiales (1988) 0.80
Antinociceptive activity of opiates in the presence of the antidepressant agent nomifensine. Neuropharmacology (1980) 0.80
Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders. Drugs Aging (1991) 0.79
The VIZIER project: preparedness against pathogenic RNA viruses. Antiviral Res (2007) 0.79
[Clinical aspects of AIDS in the Central African Republic]. Med Trop (Mars) (1986) 0.79
Differential effects of SKF 38393 and LY 141865 on nociception and morphine analgesia. Life Sci (1983) 0.79